Predict your next investment

thecliftongroup.com

See what CB Insights has to offer

Investments

3

Portfolio Exits

1

About Cliffton Group

The Clifton Group is a service provider and registered investment advisor that delivers customized investment solutions to institutional investors. The firm specializes in improving efficiency and returns while reducing performance risk through low-cost, derivative-based investment applications.

Cliffton Group Headquarter Location

Predict your next investment

The CB Insights tech market intelligence platform analyzes millions of data points on venture capital, startups, patents , partnerships and news mentions to help you see tomorrow's opportunities, today.

Latest Cliffton Group News

BioAmber closes $30M financing with LANXESS and Existing Investors

Feb 23, 2012

BioAmber closes $30M financing with LANXESS and Existing Investors 23 February 2012 Bio-succinic acid company BioAmber Inc. completed its Series C round of financing with net proceeds of $30 million. The financing was closed in two tranches; a first tranche of $20 million on 4 November 2011 with existing investors Naxos Capital, Sofinnova Partners, Mitsui & Co. Ltd. and the Cliffton Group, and a second tranche of $10 million on 6 February 2012 with specialty chemicals company LANXESS. All of BioAmber’s Series B investors participated in the Series C financing. The investment by LANXESS is the culmination of a strategic collaboration in the field of renewable, phthalate-free plasticizers. BioAmber and LANXESS are jointly developing phthalate-free plasticizers and expect to begin sampling succinic-based plasticizers in 2012. The companies are also collaborating in Sarnia, Ontario, on the establishment of BioAmber’s first world-scale bio-succinic acid manufacturing facility. LANXESS is owner of the site and will provide BioAmber with utilities and services needed to operate the facility. Concurrent with the investment, LANXESS will be joining the BioAmber board of directors and has named Jorge Noguiera, the head of LANXESS’ Functional Chemicals business unit, as its board representative.

Cliffton Group Investments

3 Investments

Cliffton Group has made 3 investments. Their latest investment was in BioAmber as part of their Series C on November 11, 2011.

CBI Logo

Cliffton Group Investments Activity

investments chart

Date

Round

Company

Amount

New?

Co-Investors

Sources

11/11/2011

Series C

BioAmber

$20M

No

5/6/2011

Series B

Subscribe to see more

$99M

Subscribe to see more

10

10/14/2009

Series A

Subscribe to see more

$99M

Subscribe to see more

10

Date

11/11/2011

5/6/2011

10/14/2009

Round

Series C

Series B

Series A

Company

BioAmber

Subscribe to see more

Subscribe to see more

Amount

$20M

$99M

$99M

New?

No

Subscribe to see more

Subscribe to see more

Co-Investors

Sources

10

10

Cliffton Group Portfolio Exits

1 Portfolio Exit

Cliffton Group has 1 portfolio exit. Their latest portfolio exit was BioAmber on May 10, 2013.

Date

Exit

Companies

Valuation
Valuations are submitted by companies, mined from state filings or news, provided by VentureSource, or based on a comparables valuation model.

Acquirer

Sources

5/10/2013

IPO

2

Date

5/10/2013

Exit

IPO

Companies

Valuation

Acquirer

Sources

2

CB Insights uses Cookies

CBI websites generally use certain cookies to enable better interactions with our sites and services. Use of these cookies, which may be stored on your device, permits us to improve and customize your experience. You can read more about your cookie choices at our privacy policy here. By continuing to use this site you are consenting to these choices.